MyFinsight
Home
Blog
About
Net income
$108M
(-25.52%↓ Y/Y)
Trade accounts
payable
$74M
(85.00%↑ Y/Y)
Amortization
$46M
(-13.21%↓ Y/Y)
Depreciation
$34M
(-5.56%↓ Y/Y)
Stock-based compensation
$25M
(13.64%↑ Y/Y)
Increase Decrease In
Other Operating...
-$16M
(80.25%↑ Y/Y)
Deferred income tax
expense (benefit)
$16M
(60.00%↑ Y/Y)
Accretion and changes in
fair value in...
-$9M
(25.00%↑ Y/Y)
Income taxes payable
$7M
(-12.50%↓ Y/Y)
Other Noncash Income
Expense
-$5M
(79.17%↑ Y/Y)
Acquired in-process
research and development...
$1M
Net cash flows
provided by operating...
$107M
(-51.36%↓ Y/Y)
Canceled cashflow
$234M
Net increase
(decrease) in cash and cash...
$16M
(-69.23%↓ Y/Y)
Canceled cashflow
$91M
Accounts receivable
$111M
(1333.33%↑ Y/Y)
Other current assets
$76M
(13.43%↑ Y/Y)
Accrued and other
current liabilities
-$20M
(79.59%↑ Y/Y)
Inventories
$15M
(-55.88%↓ Y/Y)
Unrealized foreign
exchange (gain) loss
$12M
(175.00%↑ Y/Y)
Net cash flows
provided by (used) in...
-$76M
(-100.00%↓ Y/Y)
Net cash flows used
in financing...
-$12M
(94.62%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$3M
(-103.23%↓ Y/Y)
Capital expenditures
$42M
(7.69%↑ Y/Y)
Purchase of product
rights and asset...
$34M
Dividend payments
$6M
(-40.00%↓ Y/Y)
Employee withholding
taxes related to...
$6M
(-50.00%↓ Y/Y)
Back
Back
Cash Flow
organon-logo-svg
source: myfinsight.com
Organon & Co. (OGN)
organon-logo-svg
Organon & Co. (OGN)